Detection of acute HIV infections in high-risk patients in California

被引:89
作者
Patel, P
Klausner, JD
Bacon, OM
Liska, S
Taylor, M
Gonzalez, A
Kohn, RP
Wong, W
Harvey, S
Kerndt, PR
Holmberg, SD
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
[2] STD Prevent & Control Serv City & Cty San Francis, San Francisco, CA USA
[3] Publ Hlth Lab City & Cty San Francisco, San Francisco, CA USA
[4] Los Angeles Cty Dept Hlth Serv, STD Program, Los Angeles, CA USA
[5] Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA
[6] Los Angeles Cty Dept Hlth Serv, Publ Hlth Lab, Los Angeles, CA USA
关键词
sexually transmitted disease; acute HIV infection; ribonucleic acid; syphilis; HIV detection;
D O I
10.1097/01.qai.0000218363.21088.ad
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Given the strong relationship between sexually transmitted diseases (STDs) and the spread of HIV infection, recent outbreaks of syphilis in the United States could lead to increased rates of new HIV infection. STD clinics serving persons at risk for syphilis would be logical sites to monitor rates of acute HIV infection. The detection of acute HIV infection, however, is not routine and requires the use of HIV RNA testing in combination with HIV antibody testing. Methods: To determine the rate of acute HIV infection, we performed HIV RNA testing on pooled HIV antibody-negative specimens from persons seeking care at San Francisco City Clinic (SFCC) and from trien seeking care at 3 STD clinics in Los Angeles. We compared prevalence of acute HIV infection among those groups. Results: From October 2003 to July 2004, we tested 3075 specimens from persons at the SFCC, of which 105 (3%) were HIV antibody-positive and 11 were HIV RNA-positive/HIV antibody-negative, resulting in a prevalence of acute HIV infection of 36 per 10,000 (95% confidence interval [CI]: 26 to 50 per 10,000) and increasing by 10.5% the diagnostic yield of HIV RNA testing compared with standard testing. From February 2004 to April 2004, 1712 specimens were tested from men at 3 Los Angeles STD clinics, of which 14 (0.82%) were HIV-positive by enzyme immunoassay testing and 1 was HIV RNA-positive/HIV anti body-negative, resulting in a prevalence of 6 per 10,000 (95% CI: 3 to 13 per 10,000) and increasing the diagnostic yield for HIV infection by 7.1%. Conclusions: In our study, the addition of HIV RNA screening to routine HIV antibody testing in STD clinics identified a Substantial increased proportion of HIV-infected persons at high risk for further HIV transmission, who would have been missed by routine HIV counseling and testing protocols. Further evaluation of the addition of HIV RNA screening to routine HIV antibody testing is warranted.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 31 条
[1]  
*ANG COUNT DEP HLT, 2005, EARL SYPH SURV SUMM, P1
[2]   Risk factors and clinical preservation of acute primary HIV infection in India [J].
Bollinger, RC ;
Brookmeyer, RS ;
Mehendale, SM ;
Paranjape, RS ;
Shepherd, ME ;
Gadkari, DA ;
Quinn, TC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (23) :2085-2089
[3]   TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS [J].
BUSCH, MP ;
LEE, LLL ;
SATTEN, GA ;
HENRARD, DR ;
FARZADEGAN, H ;
NELSON, KE ;
READ, S ;
DODD, RY ;
PETERSEN, LR .
TRANSFUSION, 1995, 35 (02) :91-97
[4]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P731
[5]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P575
[6]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P113
[7]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[8]   Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion [J].
Colfax, GN ;
Buchbinder, SP ;
Cornelisse, PGA ;
Vittinghoff, E ;
Mayer, K ;
Celum, C .
AIDS, 2002, 16 (11) :1529-1535
[9]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[10]   Cost comparison of three HIV counseling and testing technologies [J].
Ekwueme, DU ;
Pinkerton, SD ;
Holtgrave, DR ;
Branson, BM .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2003, 25 (02) :112-121